|
Diabetes, Vol 49, Issue 7 1096-1100, Copyright © 2000 by American Diabetes Association
Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites
AV Skurat, AD Dietrich and PJ Roach
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis 46202. USA. askurat@iupui.edu
In skeletal muscle, insulin activates glycogen synthase by reducing
phosphorylation at both NH2- and COOH-terminal sites of the enzyme and by
elevating the levels of glucose-6-phosphate, an allosteric activator of
glycogen synthase. To study the mechanism of regulation of glycogen
synthase by insulin and glucose-6-phosphate, we generated stable Rat-1
fibroblast clones expressing rabbit muscle glycogen synthase with
Ser-->Ala substitutions at key phosphorylation sites. We found that 1)
elimination of the phosphorylation of either NH2- or COOH-terminal sites
did not abolish insulin stimulation of glycogen synthase; 2) mutations at
both Ser-7 and Ser-640 were necessary to bypass insulin activation; 3)
mutation at Ser-7, coupled with the disruption of the motif for recognition
by glycogen synthase kinase-3 (GSK-3), did not eliminate the insulin
effect; and 4) mutation of either Ser-7 or Ser-640 increased the
sensitivity of glycogen synthase to glucose 6-phosphate >10-fold. We
conclude that Ser-7 and Ser-640 are both involved in mediating the response
of glycogen synthase to insulin and activation by glucose 6-phosphate. In
Rat-1 fibroblasts, GSK-3 action is not essential for glycogen synthase
activation by insulin, and GSK-3-independent mechanisms also operate.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Lindegaard, C. Frosig, A. M. W. Petersen, P. Plomgaard, S. Ditlevsen, B. Mittendorfer, G. Van Hall, J. F.P. Wojtaszewski, and B. K. Pedersen
Inhibition of Lipolysis Stimulates Peripheral Glucose Uptake but Has No Effect on Endogenous Glucose Production in HIV Lipodystrophy
Diabetes,
August 1, 2007;
56(8):
2070 - 2077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Haugaard, O. Andersen, S. Madsbad, C. Frosig, J. Iversen, J. O. Nielsen, and J. F.P. Wojtaszewski
Skeletal Muscle Insulin Signaling Defects Downstream of Phosphatidylinositol 3-Kinase at the Level of Akt Are Associated With Impaired Nonoxidative Glucose Disposal in HIV Lipodystrophy
Diabetes,
December 1, 2005;
54(12):
3474 - 3483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Parker, R. Taylor, D. Jones, and D. McClain
Hyperglycemia and Inhibition of Glycogen Synthase in Streptozotocin-treated Mice: ROLE OF O-LINKED N-ACETYLGLUCOSAMINE
J. Biol. Chem.,
May 14, 2004;
279(20):
20636 - 20642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Skurat and A. D. Dietrich
Phosphorylation of Ser640 in Muscle Glycogen Synthase by DYRK Family Protein Kinases
J. Biol. Chem.,
January 23, 2004;
279(4):
2490 - 2498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sakamoto, W. G. Aschenbach, M. F. Hirshman, and L. J. Goodyear
Akt signaling in skeletal muscle: regulation by exercise and passive stretch
Am J Physiol Endocrinol Metab,
November 1, 2003;
285(5):
E1081 - E1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hojlund, P. Staehr, B. F. Hansen, K. A. Green, D. G. Hardie, E. A. Richter, H. Beck-Nielsen, and J. F.P. Wojtaszewski
Increased Phosphorylation of Skeletal Muscle Glycogen Synthase at NH2-Terminal Sites During Physiological Hyperinsulinemia in Type 2 Diabetes
Diabetes,
June 1, 2003;
52(6):
1393 - 1402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Parker, K. C. Lund, R. P. Taylor, and D. A. McClain
Insulin Resistance of Glycogen Synthase Mediated by O-Linked N-Acetylglucosamine
J. Biol. Chem.,
March 14, 2003;
278(12):
10022 - 10027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-B. Kim, G. I. Shulman, and B. B. Kahn
Fatty Acid Infusion Selectively Impairs Insulin Action on Akt1 and Protein Kinase C lambda /zeta but Not on Glycogen Synthase Kinase-3
J. Biol. Chem.,
August 30, 2002;
277(36):
32915 - 32922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sakamoto, M. F. Hirshman, W. G. Aschenbach, and L. J. Goodyear
Contraction Regulation of Akt in Rat Skeletal Muscle
J. Biol. Chem.,
March 29, 2002;
277(14):
11910 - 11917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S.L. Thong, W. Derave, B. Kiens, T. E. Graham, B. Urso, J. F.P. Wojtaszewski, B. F. Hansen, and E. A. Richter
Caffeine-Induced Impairment of Insulin Action but Not Insulin Signaling in Human Skeletal Muscle Is Reduced by Exercise
Diabetes,
March 1, 2002;
51(3):
583 - 590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Aschenbach, Y. Suzuki, K. Breeden, C. Prats, M. F. Hirshman, S. D. Dufresne, K. Sakamoto, P. G. Vilardo, M. Steele, J.-H. Kim, et al.
The Muscle-specific Protein Phosphatase PP1G/RGL(GM) Is Essential for Activation of Glycogen Synthase by Exercise
J. Biol. Chem.,
October 19, 2001;
276(43):
39959 - 39967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Halse, S. M. Bonavaud, J. L. Armstrong, J. G. McCormack, and S. J. Yeaman
Control of Glycogen Synthesis by Glucose, Glycogen, and Insulin in Cultured Human Muscle Cells
Diabetes,
April 1, 2001;
50(4):
720 - 726.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. L. Armstrong, S. M. Bonavaud, B. J. Toole, and S. J. Yeaman
Regulation of Glycogen Synthesis by Amino Acids in Cultured Human Muscle Cells
J. Biol. Chem.,
January 5, 2001;
276(2):
952 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|